Coccidioides immitis in patients with human immunodeficiency virus infections

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Coccidioidomycosis in human-immunodeficiency virus-infected patients poses frequent and significant problems. Most cases are presently concentrated in regions highly endemic for the fungus. Infection most frequently involves the lungs, and diffuse reticulonodular infiltrates are typical. Disease has also been evident in extrapulmonary sites including meningitis. When progressive disease occurs, most patients already have low CD4 lymphocyte counts. In such cases, effective therapies have included amphotericin B, ketoconazole, and newer investigational agents such as itraconazole, and fluconazole. Although coccidioidal infections have developed in only a few patients away from the endemic regions, those that have suggest that reactivation is possible.

Original languageEnglish (US)
Pages (from-to)151-154
Number of pages4
JournalSeminars in Respiratory Infections
Volume5
Issue number2
StatePublished - Jun 1990

Fingerprint

Coccidioides
Virus Diseases
HIV
Coccidioidomycosis
Ketoconazole
Itraconazole
Fluconazole
Amphotericin B
CD4 Lymphocyte Count
Infection
Meningitis
Fungi
Lung
Therapeutics

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Microbiology (medical)

Cite this

Coccidioides immitis in patients with human immunodeficiency virus infections. / Galgiani, John N; Ampel, Neil M.

In: Seminars in Respiratory Infections, Vol. 5, No. 2, 06.1990, p. 151-154.

Research output: Contribution to journalArticle

@article{e18ea2a6506947ec844f80c658635efc,
title = "Coccidioides immitis in patients with human immunodeficiency virus infections",
abstract = "Coccidioidomycosis in human-immunodeficiency virus-infected patients poses frequent and significant problems. Most cases are presently concentrated in regions highly endemic for the fungus. Infection most frequently involves the lungs, and diffuse reticulonodular infiltrates are typical. Disease has also been evident in extrapulmonary sites including meningitis. When progressive disease occurs, most patients already have low CD4 lymphocyte counts. In such cases, effective therapies have included amphotericin B, ketoconazole, and newer investigational agents such as itraconazole, and fluconazole. Although coccidioidal infections have developed in only a few patients away from the endemic regions, those that have suggest that reactivation is possible.",
author = "Galgiani, {John N} and Ampel, {Neil M.}",
year = "1990",
month = "6",
language = "English (US)",
volume = "5",
pages = "151--154",
journal = "Seminars in Respiratory Infections",
issn = "0882-0546",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Coccidioides immitis in patients with human immunodeficiency virus infections

AU - Galgiani, John N

AU - Ampel, Neil M.

PY - 1990/6

Y1 - 1990/6

N2 - Coccidioidomycosis in human-immunodeficiency virus-infected patients poses frequent and significant problems. Most cases are presently concentrated in regions highly endemic for the fungus. Infection most frequently involves the lungs, and diffuse reticulonodular infiltrates are typical. Disease has also been evident in extrapulmonary sites including meningitis. When progressive disease occurs, most patients already have low CD4 lymphocyte counts. In such cases, effective therapies have included amphotericin B, ketoconazole, and newer investigational agents such as itraconazole, and fluconazole. Although coccidioidal infections have developed in only a few patients away from the endemic regions, those that have suggest that reactivation is possible.

AB - Coccidioidomycosis in human-immunodeficiency virus-infected patients poses frequent and significant problems. Most cases are presently concentrated in regions highly endemic for the fungus. Infection most frequently involves the lungs, and diffuse reticulonodular infiltrates are typical. Disease has also been evident in extrapulmonary sites including meningitis. When progressive disease occurs, most patients already have low CD4 lymphocyte counts. In such cases, effective therapies have included amphotericin B, ketoconazole, and newer investigational agents such as itraconazole, and fluconazole. Although coccidioidal infections have developed in only a few patients away from the endemic regions, those that have suggest that reactivation is possible.

UR - http://www.scopus.com/inward/record.url?scp=0025074492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025074492&partnerID=8YFLogxK

M3 - Article

C2 - 2247710

AN - SCOPUS:0025074492

VL - 5

SP - 151

EP - 154

JO - Seminars in Respiratory Infections

JF - Seminars in Respiratory Infections

SN - 0882-0546

IS - 2

ER -